NCT04787003View on ClinicalTrials.gov

Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

October 1, 2023

Study Completion Date

February 28, 2024

Conditions

Neoplasms

Interventions

DRUG

oncolytic virus (OVV-01) injection

intratumoral injection of OVV-01 with or without immune checkpoint inhibitors

Trial Locations (1)

062552

RECRUITING

North China Petroleum Bureau General Hospital, Cangzhou

Sponsors

Collaborators (1)

Joint Biosciences Ltd

All Listed Sponsors

collaborator

Joint Biosciences Ltd

UNKNOWN

lead

North China Petroleum Bureau General Hospital

OTHER